194 related articles for article (PubMed ID: 22307849)
1. microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells.
Li S; Chen T; Zhong Z; Wang Y; Li Y; Zhao X
Mol Med Rep; 2012 Apr; 5(4):949-54. PubMed ID: 22307849
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
[TBL] [Abstract][Full Text] [Related]
3. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
[TBL] [Abstract][Full Text] [Related]
6. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
[TBL] [Abstract][Full Text] [Related]
7. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional role of miR-29b in renal cell carcinoma.
Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
[TBL] [Abstract][Full Text] [Related]
9. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
12. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM
Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828
[TBL] [Abstract][Full Text] [Related]
13. miR-206 inhibits renal cell cancer growth by targeting GAK.
Wei C; Wang S; Ye ZQ; Chen ZQ
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
[TBL] [Abstract][Full Text] [Related]
14. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
Deng JH; Zheng GY; Li HZ; Ji ZG
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
[TBL] [Abstract][Full Text] [Related]
16. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
18. LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
Na XY; Hu XQ; Zhao Y; Hu CH; Shang XS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1291-1301. PubMed ID: 33629299
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.
Hou W; Tian Q; Zheng J; Bonkovsky HL
Hepatology; 2010 May; 51(5):1494-504. PubMed ID: 20127796
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]